Patents by Inventor Youssef L. Bennani

Youssef L. Bennani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6515013
    Abstract: Compounds of formula I are useful in treating diseases or conditions prevented by or ameliorated with histamine-3 receptor ligands. Also disclosed are histamine-3 receptor ligand compositions and methods of antagonizing or agonizing histamine-3 receptors.
    Type: Grant
    Filed: July 11, 2001
    Date of Patent: February 4, 2003
    Assignee: Abbott Laboratories
    Inventors: Youssef L. Bennani, Ramin Faghih, Wesley J. Dwight, Anil Vasudevan, Scott E. Conner
  • Publication number: 20020183309
    Abstract: Compounds of formula (I) 1
    Type: Application
    Filed: January 11, 2002
    Publication date: December 5, 2002
    Inventors: Marlon D. Cowart, Youssef L. Bennani, Ramin Faghih, Lawrence A. Black
  • Publication number: 20020177589
    Abstract: Compounds of formula (I) 1
    Type: Application
    Filed: March 16, 2001
    Publication date: November 28, 2002
    Inventors: Marlon D. Cowart, Youssef L. Bennani, Ramin Faghih
  • Publication number: 20020169188
    Abstract: Compounds of formula (I) 1
    Type: Application
    Filed: February 25, 2002
    Publication date: November 14, 2002
    Inventors: Marlon D. Cowart, Youssef L. Bennani, Ramin Faghih, Gregory A. Gfesser, Lawrence A. Black
  • Publication number: 20020123528
    Abstract: Compounds of formula (I) 1
    Type: Application
    Filed: November 1, 2001
    Publication date: September 5, 2002
    Inventor: Youssef L. Bennani
  • Publication number: 20020035103
    Abstract: Compounds of formula I 1
    Type: Application
    Filed: July 11, 2001
    Publication date: March 21, 2002
    Inventors: Youssef L. Bennani, Ramin Faghih, Wesley J. Dwight, Anil Vasudevan, Scott E. Conner
  • Publication number: 20010049367
    Abstract: Compounds of formula (I) 1
    Type: Application
    Filed: March 5, 2001
    Publication date: December 6, 2001
    Inventors: Youssef L. Bennani, Lawrence A. Black, Wesley J. Dwight, Ramin Faghih, Robert G. Gentles, Huaqing Liu, Kathleen M. Phelan, Anil Vasudevan, Henry Q. Zhang
  • Patent number: 6316475
    Abstract: Compounds of formula (I) are useful in treating diseases or conditions prevented by or ameliorated with histamine-3 receptor ligands.
    Type: Grant
    Filed: November 17, 2000
    Date of Patent: November 13, 2001
    Assignee: Abbott Laboratories
    Inventors: Youssef L. Bennani, Ramin Faghih
  • Patent number: 5770378
    Abstract: Tricyclic retinoids having activity for retinoic acid receptors and/or retinoid X receptors are provided. Also provided are pharmaceutical compositions incorporating such tricyclic retinoid compounds and methods for their therapeutic use.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: June 23, 1998
    Assignee: Ligand Pharmaceuticals, Inc.
    Inventors: Chan Kou Hwang, Steven K. White, Youssef L. Bennani, Stacie S. Canan Koch, Beth Ann Badea, Jonathan J. Hebert, Alex M. Nadzan
  • Patent number: 5770383
    Abstract: Tricyclic retinoids having activity for retinoic acid receptors and/or retinoid X receptors are provided. Also provided are pharmaceutical compositions incorporating such tricyclic retinoid compounds and methods for their therapeutic use.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: June 23, 1998
    Assignee: Ligand Pharmaceuticals, Inc.
    Inventors: Chan Kou Hwang, Steven K. White, Youssef L. Bennani, Stacie S. Canan Koch, Beth Ann Badea, Jonathan J. Hebert, Luc J. Farmer, Alex M. Nadzan
  • Patent number: 5721103
    Abstract: Novel trienoic compounds having activity for retinoic acid receptors and retinoid X receptors are provided. Also provided are pharmaceutical compositions incorporating such compounds and methods for their use.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: February 24, 1998
    Assignee: Ligand Pharmaceuticals Incorporated
    Inventors: Marcus F. Boehm, Lin Zhang, Youssef L. Bennani, Alex M. Nadzan
  • Patent number: 5514821
    Abstract: Methods for the synthesis of dideuterium and/or ditritium ring-labeled retinoids and intermediates, and their use in the discovery of Retinoid X Receptor ligands are provided. In addition, dideuterium and/or ditritium ring-labeled retinoids and novel intermediates, as well as methods for their use in ligand binding and mass spectral studies are also provided.
    Type: Grant
    Filed: May 27, 1994
    Date of Patent: May 7, 1996
    Assignee: Ligand Pharmaceuticals Incorporated
    Inventors: Youssef L. Bennani, Marcus F. Boehm